is farxiga a glp-1 drug glp 1 agonist Receptor Agonists as Treatments for Type 2 Diabetes Farxiga (Dapagliflozin) Prescriptions Available Today
Description
In June 2024, Zealand Pharma announced a share issuance to raise DKK 7 billion ($1 billion) to advance its obesity candidates
%203_2.webp?width=1600&height=1067&name=Farxiga%20(dapagliflozin)%203_2.webp)
For example, medications like ACE inhibitors , ARBs , and beta-blockers generally do not interfere with the cardiovascular benefits of GLP-1 therapies
The substantial metabolic changes triggered by GLP-1Ra in PwO could potentially influence the fracture risk beyond its effects on BMD and BTMs

Acute Kidney Injury On the FDA label for Ozempic, acute kidney injury and worsening of chronic renal failure is listed as a potential adverse reaction

Besch G, Perrotti A, Mauny F, et al

95% CI, 0.621.79) [12]
